Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South Africa

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Pennsylvania

About this trial

Consistent use of antiretroviral therapy (ART) is essential for achieving suppression among people with HIV (PWH). Yet despite improvements in access to ART and improving viral suppression rates, an estimated one-third of PWH globally do not take ART as prescribed, thus allowing the virus to remain detectable and transmissible. This study tests whether a low-cost visual education tool, B-OK bottles, improves understanding of HIV, antiretroviral therapy (ART), and the concept of Undetectable = Untransmittable (U=U) among adults in Gauteng, South Africa using a randomized trial. Participants will be randomly assigned to one of three groups: (1) standard-of-care verbal information based on Department of Health guidelines, (2) information delivered in person using B-OK bottles, or (3) information delivered via a video demonstrating the B-OK bottles. The study will compare the two intervention formats to standard care, and to each other, to assess whether the tool improves knowledge, attitudes, and intentions related to HIV treatment and prevention, and whether the intervention results depend on delivery mode (in-person vs. video). Outcomes will be measured at baseline, immediately after the intervention, and at six-week follow-up.

Eligibility criteria

Qualifiers

Aged 18 years or older

Residing in Gauteng

Able to understand and communicate in English or another study-supported language

Willing to attend an in-person study visit at the HE2RO offices

Disqualifiers

Unwilling or unable to provide written informed consent for study participation

Trial design

Treatments tested in this trial

  • B-OK Bead Bottles Intervention (delivered in person)
  • B-OK Bottles Intervention (delivered by video)
  • Control

Treatment groups

600 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

University of Pennsylvania

Lead sponsor

Health Economics and Epidemiology Research Office, University of the Witwatersrand

Collaborator